INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Friendshoring: A Strategic Shift In Pharma Supply Chains

  To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.

• The Importance Of Quality In Raw Material Selection

  Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization. 

• The Team For Your Package Design Needs

  Our dedicated team of in-house design specialists deliver insightful packaging design and practical knowledge to deliver differentiated and cost-effective packaging solutions.

• Integrated Single-Site CDMO Model

  A single‑site model reduces handoff risks, speeds timelines, strengthens quality oversight, and unifies development and manufacturing to improve reliability and execution efficiency.

• Optimizing End-To-End Contract Analytical Support For Cell And Gene Therapies

  7/11/2024

  The development and production of CGTs presents unparalleled complexities. Learn how a partner with robust end-to-end services can help you overcome challenges at every step of the drug lifecycle.

• How To Select The Right Fill-Finish CDMO For Phase I–II

  3/16/2026

  Early‑phase programs require flexible, technically aligned fill‑finish partners. Mid‑sized CDMOs offer a balance of agility, infrastructure, and regulatory maturity suited to Phase I–II needs.

• Supply Chain Efficiency And Sourcing In Gene Therapy

  11/4/2025

  An overview of the inbound supply chain in gene therapy and the process development challenges that are frequently faced. Learn about concepts such as scaling, cell culture media sourcing, mixing technologies, and configurable packaging.

• Building A Resilient Supply Chain For Your Next-Generation Peptide Therapeutic

  1/23/2025

  As peptide therapeutics continue to establish themselves as a leading technology for treating chronic indications, drug sponsors must identify reliable peptide building block suppliers to secure high-quality starting materials.

• Biopharma Supply, Reimagined: Regional, Resilient Manufacturing

  4/1/2026

  Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.